Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory bowel disease: immunologic concepts.

S Schreiber1

  • 11st Department of Medicine, Christian-Albrechts University, Kiel, Germany. s.schreiber@mucosa.de

Hepato-Gastroenterology
|February 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between olfactory function and quality of life in COVID-19 patients.

Rhinology·2026
Same author

Simvastatin impairs fracture healing under ischemic conditions.

Frontiers in pharmacology·2025
Same author

scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome.

Nature communications·2025
Same author

[Value of retrograde femoral nailing : Pros and cons].

Unfallchirurgie (Heidelberg, Germany)·2025
Same author

Zeitschrift fur Gastroenterologie·2024
Same author

Zeitschrift fur Gastroenterologie·2023

Recent advances in understanding chronic intestinal inflammation have led to new therapies like infliximab for Crohn's disease. Future research into genetic causes promises further improvements in anti-inflammatory treatments.

Area of Science:

  • Gastroenterology and Immunology
  • Molecular Biology

Background:

  • Significant progress in understanding chronic intestinal inflammation pathophysiology over the last decade.
  • Emergence of novel biologic therapies targeting key inflammatory mediators.

Purpose of the Study:

  • To review the advancements in chronic intestinal inflammation understanding and treatment.
  • To highlight the role of novel drugs in managing Crohn's disease.
  • To discuss future directions in anti-inflammatory therapy and genetic research.

Main Methods:

  • Literature review of recent studies on chronic intestinal inflammation.
  • Analysis of therapeutic strategies for Crohn's disease.
  • Exploration of genetic factors in inflammatory bowel disease.

Related Experiment Videos

Main Results:

  • Introduction of tumor necrosis factor alpha binding proteins, such as infliximab, into Crohn's disease management.
  • Increased efficacy of anti-inflammatory therapy is expected with better understanding of pathophysiology and mediators.
  • Genetic etiology exploration shows promise for future therapeutic advancements.

Conclusions:

  • Novel drugs like infliximab represent a significant step in managing Crohn's disease.
  • Continued research into disease mechanisms and genetics is crucial for enhancing anti-inflammatory treatment efficacy.
  • The future of inflammatory bowel disease treatment lies in personalized medicine informed by genetic insights.